414 results match your criteria: "Rene Descartes University[Affiliation]"

Secondary Prevention Therapies in Real-World Patients with Myocardial Infarction: Eligibility Based on Randomized Trials Supporting European and American Guidelines.

Am J Med

February 2024

Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain; Cardiology Department, Hospital Universitario 12 de Octubre, and Instituto de Investigación i+12, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain. Electronic address:

Objective: We aimed to evaluate the applicability of the eligibility criteria of randomized controlled trials (RCTs) cited in guideline recommendations in a real-world cohort of patients receiving secondary prevention after acute myocardial infarction from the EPICOR registries.

Methods: Recommendations provided by American and European guidelines for acute myocardial infarction were classified into general (applying to all patients) and specific (applying to patients with left ventricular dysfunction or heart failure). Randomized controlled trials cited in these recommendations were selected, and their entry criteria were applied to our international cohort of 18,117 patients.

View Article and Find Full Text PDF

Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: Insights from an international cohort of 23,489 patients with acute coronary syndrome.

Am Heart J

October 2023

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Cardiology Department, Hospital Universitario 12 de Octubre, and Instituto de investigación i+12, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. Electronic address:

Background: Controversial findings have been reported in the literature regarding the impact of the absence of standard modifiable cardiovascular risk factors (SMuRFs) on long-term mortality risk in patients with acute coronary syndrome (ACS). While the prognostic additive value of SMuRFs has been well described, the prognostic role of prior cardiovascular disease (CVD) by sex is less well-known in patients with and without SMuRFs.

Methods: EPICOR and EPICOR Asia are prospective, observational registries conducted between 2010 and 2014, which enrolled ACS patients in 28 countries across Europe, Latin America, and Asia.

View Article and Find Full Text PDF

Emotional speech perception is a multisensory process. When speaking with an individual we concurrently integrate the information from their voice and face to decode e.g.

View Article and Find Full Text PDF

Background And Purpose: Chemotherapy-induced neutropenia and neutrophil-to-lymphocyte ratio (NLR) are potentially useful prognostic markers in patients with metastatic castration-resistant prostate cancer (mCRPC). This post hoc analysis investigated whether these markers can be utilized for dose considerations and evaluated the prognostic impact of leukocyte subtypes.

Patients And Methods: PROSELICA assessed the non-inferiority of cabazitaxel 20 mg/m (C20;  = 598) 25 mg/m (C25;  = 602) for overall survival (OS) in patients with mCRPC previously treated with docetaxel.

View Article and Find Full Text PDF
Article Synopsis
  • * A 3D V-NET model, trained on 1218 baseline 18FDG-PET/CT scans, achieved strong segmentation performance with mean dice scores of 0.84 for training and validation sets, and a slightly lower score of 0.76 for the test set.
  • * The deep learning model shows significant potential to reduce the time required for TMTV computation while maintaining high accuracy, with Spearman's correlations between manual and predicted TMTV ranging from 0.92
View Article and Find Full Text PDF

Objective: To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation.

Design: Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF).

Setting: 1317 participating sites in 35 countries.

View Article and Find Full Text PDF

Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).

Blood Cells Mol Dis

December 2021

Neutrophil Monitoring Laboratory, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. CGD patients suffer from severe, recurrent bacterial and fungal infections. The disease is caused by mutations in the genes encoding the components of the leukocyte NADPH oxidase.

View Article and Find Full Text PDF

Background And Purpose: The objective of the study was to assess the effectiveness of individual direct oral anticoagulants versus vitamin K antagonists for primary prevention of stroke (ischemic and hemorrhagic) in routine clinical practice in patients with various clinical risk factors depending on their atrial fibrillation (AF) patterns.

Methods: A nested case-referent study was conducted using data from 2 national registries of patients with stroke and AF. Stroke cases with previous history of AF were matched to up to 2 randomly selected referent patients with AF and no stroke.

View Article and Find Full Text PDF

Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).

Blood Cells Mol Dis

September 2021

Neutrophil Monitoring Laboratory, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. CGD patients suffer from severe bacterial and fungal infections. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase.

View Article and Find Full Text PDF

Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality.

Rev Esp Cardiol (Engl Ed)

May 2022

Laboratorio Traslacional para la Imagen y Terapia Cardiovascular, Centro Nacional de Investigaciones Cardiovasculares Carlos (CNIC), Madrid, Spain; Instituto de Investigación i+12 y Departamento de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. Electronic address:

Introduction And Objectives: Although several factors associated with sex differences in the management and outcomes after acute coronary syndrome (ACS) have been reported, little is known about the influence of socioeconomic factors on sex disparities. Our aim was to evaluate the influence of country wealth and income inequality on national sex differences in mortality after ACS.

Methods: Sex differences in 2-year postdischarge mortality were evaluated in 23 489 ACS patients from the EPICOR and EPICOR Asia registries.

View Article and Find Full Text PDF

Background: The phase III PROSELICA (NCT01308580) and FIRSTANA (NCT01308567) trials investigated taxane chemotherapy among men with postdocetaxel metastatic, castration-resistant prostate cancer (mCRPC) or chemotherapy-naïve mCRPC, respectively. We present a post hoc analysis of patient-reported health-related quality of life (HRQL) among patients with or without a clinical (pain, tumor, or prostate-specific antigen [PSA]) response.

Materials And Methods: PROSELICA and FIRSTANA HRQL and pain data were collected and analyzed using protocol-defined Functional Assessment of Cancer Therapy-Prostate (FACT-P) and McGill-Melzack (Present Pain Intensity scale) questionnaires.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the characteristics, treatment, and outcomes over two years for patients with newly diagnosed non-valvular atrial fibrillation at risk for stroke in Nordic countries.
  • A total of 2,396 patients from Nordic countries were analyzed, showing higher use of oral anticoagulants compared to Non-Nordic European patients, particularly NOACs, which were prescribed more often and with less use of antiplatelet monotherapy.
  • While all-cause mortality and non-haemorrhagic stroke rates were similar across groups, Nordic patients experienced significantly higher rates of major bleeding.
View Article and Find Full Text PDF

Background: Men with metastatic castration-resistant prostate cancer (mCRPC) are living longer, therefore optimizing health-related quality of life (HRQL), as well as survival outcomes, is important for optimal patient care. The aim of this study was to assess the HRQL in patients with mCRPC receiving docetaxel or cabazitaxel.

Patients And Methods: PROSELICA (NCT01308580) assessed the non-inferiority of cabazitaxel 20 mg/m (C20) versus 25 mg/m (C25) in patients with mCRPC after docetaxel.

View Article and Find Full Text PDF

Background: Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) on structural lesions in patients with recent-onset axial spondyloarthritis (axSpA). We compared 2-year structural lesion changes on magnetic resonance imaging (MRI) in the sacroiliac joints (SIJ) of patients with recent-onset axSpA receiving etanercept in a clinical trial (EMBARK) to similar patients not receiving biologics in a cohort study (DESIR). We also evaluated the relationship between the Ankylosing Spondylitis Disease Activity Score (ASDAS) and change in MRI structural parameters.

View Article and Find Full Text PDF

Antithrombotic drug use for acute coronary syndromes (ACS) varies considerably. The number of antithrombotic drugs (excluding oral anticoagulants) used pre- and in-hospital was recorded in ACS survivors enrolled at hospital discharge in the long-tErm follow-uP of antithrombotic management patterns In acute CORonary syndrome patients (EPICOR) registry ( NCT01171404 ), a prospective cohort study. Among 10,568 patients, the number of antithrombotic drugs used early/patient ranged from 0 to 8 (interquartile range = 3-4).

View Article and Find Full Text PDF

Given the very poor prognosis for children with recurrent medulloblastoma, we aimed to identify prognostic factors for survival post-relapse in children with childhood medulloblastoma. We retrospectively collected clinico-biological data at diagnosis and main clinical characteristics at relapse of children newly diagnosed with a medulloblastoma between 2007 and 2017 at Gustave Roussy and Necker Hospital. At a median follow-up of 6.

View Article and Find Full Text PDF

First Description of a Helicopter-Borne ECPR Team for Remote Refractory Out-of-Hospital Cardiac Arrest.

Prehosp Emerg Care

January 2021

SAMU de Paris-ICU, Necker University Hospital, Assistance publique-Hopitaux de Paris, Paris, France (AH, CD, JHR, AM, KA, PC, LL); INSERM U955, Equipe 3, École Nationale Vétérinaire d'Alfort, Université Paris-Est Créteil, Paris, France (AH); SAMU-SMUR 95, Centre Hospitalier René Dubois, Pontoise, France (AR-H); SAMU-SMUR 77, Centre Hospitalier Marc Jaquet, Melun, France (NB); SAMU-SMUR 91, Centre Hospitalier Sud Francilien, Corbeil-Essones, France (AD); René Descartes University, Paris, France (PC, LL); INSERM U970, Unité 4 SDEC, Paris, France (LL).

Access time to extracorporeal cardiopulmonary resuscitation (ECPR) refractory out of hospital cardiac arrest (OHCA) is a crucial factor. In our region, some patients are not eligible to this treatment due to the impossibility to reach the hospital with reasonable delay (ideally 60 min). In order to increase accessibility for patients far from ECPR centers, we developed a helicopter-borne ECPR-team which is sent out to the patient for ECPR implementation on the scene of the OHCA.

View Article and Find Full Text PDF

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry.

Intern Emerg Med

April 2021

Chair of Cardiology, University Cardiology Division, University of Pisa, Pisa University Hospital, Pisa, and Fondazione VillaSerena Per La Ricerca, Città Sant'Angelo, Pescara, Italy.

The management of patients with atrial fibrillation (AF) has rapidly changed with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs) and changes in the use of rhythm control therapy. The prevention of thromboembolic events European Registry in Atrial Fibrillation Prolongation Registry (PREFER Prolongation) enrolled consecutive patients with AF on NOACs between 2014 and 2016 in a multicentre, prospective, observational study with one-year follow-up, focusing on the time of introduction of NOACs. Overall, 3783 patients were enrolled, with follow-up information available in 3223 (85%).

View Article and Find Full Text PDF

Background And Objectives: The histopathologic classification for ANCA-associated GN distinguishes four classes on the basis of patterns of injury. In the original validation study, these classes were ordered by severity of kidney function loss as follows: focal, crescentic, mixed, and sclerotic. Subsequent validation studies disagreed on outcomes in the crescentic and mixed classes.

View Article and Find Full Text PDF

The Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) examined real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with newly diagnosed AF at risk of stroke/systemic embolism, enrolled at over 1000 centers in 35 countries. It aimed to capture data on AF burden, patients' clinical profile, patterns of clinical practice and antithrombotic management, focusing on stroke/systemic embolism prevention, uptake of new oral anticoagulants, impact on death and bleeding. GARFIELD-AF set new standards for quality of data collection and analysis.

View Article and Find Full Text PDF

Background: Malignant brain tumors (BT) are among the cancers most frequently associated with constitutional mismatch repair deficiency (CMMRD), a rare childhood cancer predisposition syndrome resulting from biallelic germline mutations in mismatch repair genes. This study analyzed data from the European "Care for CMMRD" (C4CMMRD) database to describe their clinical characteristics, treatments, and outcome with the aim of improving its diagnosis/treatment.

Methods: Retrospective analysis of data on patients with CMMRD and malignant BT from the C4CMMRD database up to July 2017.

View Article and Find Full Text PDF

Epidemic Diseases and Chinese Medicine: Example of SARS and COVID-19: Part Two.

Chin Med Cult

July 2020

Georges Pompidou European Hospital Anti-Pain Center, Faculty of Medicine, Paris V René Descartes University, Paris, France.

Along with the legends about epidemic demons, China has developed over the centuries a medical approach to epidemic diseases based on the teachings of ( ), ( ), and ( ). Other doctors and scientists participated in this evolution of knowledge, like Wang Shuhe (), Ge Hong (), Chao Yuanfang (), Sun Simiao (), and Liu Wansu (). However, it was in the 17 century, after the great break of the Song, Jin, and Yuan eras that an innovative spirit, Wu Youke ( 1582-1652) first foresaw the existence of microorganisms as we know them now.

View Article and Find Full Text PDF